SCOPUS 정보 검색 플랫폼

Journal of Clinical Oncology

Volumn 20, Issue 11, 2002, Pages 2607-2609

Thalidomide in solid malignancies

(1) Eisen, Tim a

a ROYAL MARSDEN HOSPITAL (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DEXAMETHASONE; ETOPOSIDE; INTERFERON; TEMOZOLOMIDE; THALIDOMIDE;

ANGIOGENESIS; CLINICAL TRIAL; CONSTIPATION; EDITORIAL; GLIOMA; HUMAN; KAPOSI SARCOMA; KIDNEY CARCINOMA; LETHARGY; META ANALYSIS; MULTIPLE MYELOMA; MYELODYSPLASIA; MYELOMA; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SOLID TUMOR;

EID: 0036605759 PISSN: 0732183X EISSN: None Source Type: Journal
DOI: 10.1200/JCO.2002.20.11.2607 Document Type: Editorial

Times cited : (33)

References (24)

1
- 47349113508
- Thalidomide and congenital abnormalities
- letter
- (1961) Lancet , vol.2 , pp. 1358
- McBride, W.G.¹

2
- 49749219257
- Thalidomide and congenital abnormalities
- letter
- (1962) Lancet , vol.1 , pp. 45
- Lenz, W.¹

3
- 0028216334
- Thalidomide is an inhibitor of angiogenesis
- (1994) Proc Natl Acad Sci U S A , vol.91 , pp. 4082-4085
- D'Amato, R.J.¹ Loughnan, M.S.² Flynn, E.³

4
- 0028567521
- Use of thalidomide in leprosy
- (1994) Adverse Drug React Toxicol Rev , vol.13 , pp. 177-192
- Crawford, C.L.¹

5
- 0026514939
- Thalidomide for the treatment of chronic graft-versus-host disease
- (1992) N Engl J Med , vol.326 , pp. 1055-1058
- Vogelsang, G.B.¹ Farmer, E.R.² Hess, A.D.³

6
- 8244247121
- Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection
- (1997) N Engl J Med , vol.336 , pp. 1487-1493
- Jacobson, J.M.¹ Greenspan, J.S.² Spritzler, J.³

7
- 0029087486
- Effect of thalidomide on tumour necrosis factor production and anti-tumour activity induced by 5,6-dimethylxantheone-4-acetic acid
- (1995) Br J Cancer , vol.72 , pp. 339-343
- Ching, L.M.¹ Xu, Z.F.² Gummer, B.H.³

8
- 0032748385
- Antitumour activity of thalidomide in refractory multiple myeloma
- (1999) N Engl J Med , vol.341 , pp. 1565-1571
- Singhal, S.¹ Mehta, J.² Desikan, R.³

9
- 0036155876
- Thalidomide for the treatment of patients with myelodysplastic syndromes
- (2002) Leukemia , vol.16 , pp. 1-16
- Strupp, C.¹ Germing, U.² Aivado, M.³

10
- 0036178599
- Thalidomide in cancer
- (2002) Biomed Pharmacother , vol.56 , pp. 4-12
- Singhal, S.¹ Mehta, J.²

11
- 0033916672
- Activity of thalidomide in AIDS-related Kaposi's sarcoma
- (2000) J Clin Oncol , vol.18 , pp. 2593-2602
- Little, R.¹ Wyvill, K.² Pluda, J.³

12
- 0033980850
- Continuous low dose thalidomide: A phase II study in advanced melanoma, renal cell, ovarian and breast cancer
- (2000) Br J Cancer , vol.82 , pp. 812-817
- Eisen, T.¹ Boshoff, C.² Mak, I.³

13
- 17944362585
- The treatment of advanced renal cell cancer with high-dose oral thalidomide
- (2001) Br J Cancer , vol.85 , pp. 953-958
- Stebbing, J.¹ Benson, C.² Eisen, T.³

14
- 0036139999
- Phase II trial of thalidomide for patients with advanced renal cell carcinoma
- (2002) J Clin Oncol , vol.20 , pp. 302-306
- Motzer, R.¹ Berg, W.² Ginsberg, M.³

15
- 0035051092
- Thalidomide as an anti-angiogenic agent in relapsed gliomas
- (2001) J Neurooncol , vol.51 , pp. 41-45
- Short, S.¹ Traish, D.² Dowe, A.³

16
- 0035895104
- Salvage therapy for multiple myeloma with thalidomide and CED chemotherapy
- (2001) Blood , vol.98 , pp. 3846-3848
- Moehler, T.¹ Neben, K.² Benner, A.³

17
- 0034795178
- A randomized phase II trial of docetaxel plus thalidomide in androgen-independent prostate cancer
- Semin Oncol , vol.28 , Issue.4 SUPPL. 15 , pp. 62-66
- Figg, W.¹ Arlen, P.² Gulley, J.³

18
- 0036499274
- Unexpected toxicity of combination thalidomide and interferon alfa-2a treatment in metastatic renal cell carcinoma
- letter
- (2002) J Clin Oncol , vol.20 , pp. 1429-1430
- Nathan, P.¹ Gore, M.² Eisen, T.³

19
- 0036605798
- Temozolomide plus thalidomide in patients with advanced melanoma: Results of a dose-finding trial
- (2002) J Clin Oncol , vol.20 , pp. 2610-2615
- Hwu, W.-J.¹ Krown, S.E.² Panageas, K.S.³

20
- 0032188739
- Phase I trial of temozolomide using an extended continuous oral schedule
- (1998) Cancer Res , vol.58 , pp. 4363-4367
- Brock, C.¹ Newlands, E.² Wedge, S.³

21
- 0032100486
- Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production and cytotoxic responses in the CD8+ subset
- (1998) J Exp Med , vol.187 , pp. 1885-1892
- Haslett, P.¹ Corral, L.² Albert, M.³

22
- 0029925419
- Thalidomide selectively modulates the density of cell surface molecules involved in the cell adhesion cascade
- (1996) Immunopharmacology , vol.31 , pp. 213-221
- Geitz, H.¹ Handt, S.² Zwingenberger, K.³

23
- 0035186865
- Thalidomide and its analogues inhibit lipopolysaccharide-mediated induction of cyclooxgenase-2
- (2001) Clin Cancer Res , vol.7 , pp. 3349-3355
- Fujita, J.¹ Mestre, J.² Zeldis, J.³

24
- 0035045564
- Multiple myeloma: Advances in disease biologyTherapeutic implications
- Semin Hematol , vol.38 , Issue.2 SUPPL. 3 , pp. 6-10
- Anderson, K.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.